Bilobalide is used as a neuroprotective and psychotropic agent; it is primarily employed in the treatment of neurological disorders, cerebral diseases, and spinal cord disorders; it exhibits anti-aging effects; it lowers blood pressure, reduces heart rate, and increases coronary blood flow; it protects against myocardial ischemia-reperfusion injury; it antagonizes platelet-activating factor (PAF)-induced abnormal platelet aggregation and thrombosis, thereby reducing plasma and whole blood viscosity; it demonstrates protective effects on the central nervous system, including improving learning and memory, reducing oxidative stress by increasing SOD activity and decreasing MDA levels, inhibiting cholinesterase activity and nitric oxide (NO) production; it shows therapeutic efficacy in cerebrovascular diseases such as vascular dementia, cerebral ischemia, and hypoxia-induced metabolic disturbances; it alleviates symptoms associated with age-related cognitive decline, including memory loss, disorientation, impaired concentration, sensory disturbances, paralysis, muscle atrophy, tremors, headaches, limb pain, speech disorders, visual and auditory dysfunction, dizziness, and neuromuscular coordination deficits.